Search research articles
Contact Us
Filters
Showing results (131-140 of 325) with videos related to
Page
of 33
Sort By:
Leukemia & Lymphoma
|
February 9, 2018
Reasons for initiation of treatment and predictors of response for patients with Rai stage 0/1 chronic lymphocytic leukemia (CLL) receiving first-line therapy: an analysis of the Connect<sup>®</sup> CLL cohort study
Christopher R Flowers, Chadi Nabhan, Neil E Kay, et al.
Cancer Genetics and Cytogenetics
|
December 16, 2010
Progressive but previously untreated CLL patients with greater array CGH complexity exhibit a less durable response to chemoimmunotherapy
Neil E Kay, Jeanette E Eckel-Passow, Esteban Braggio, et al.
Cancer Genetics and Cytogenetics
|
April 25, 2006
Metaphase cells with normal G-bands have cryptic interstitial deletions in 13q14 detectable by fluorescence in situ hybridization in B-cell chronic lymphocytic leukemia
Kimberly J Stockero, Stephanie R Fink, Stephanie A Smoley, et al.
Blood
|
May 6, 2009
De novo deletion 17p13.1 chronic lymphocytic leukemia shows significant clinical heterogeneity: the M. D. Anderson and Mayo Clinic experience
Constantine S Tam, Tait D Shanafelt, William G Wierda, et al.
Haematologica
|
August 6, 2013
Chronic lymphocytic leukemia in young (≤ 55 years) patients: a comprehensive analysis of prognostic factors and outcomes
Sameer A Parikh, Kari G Rabe, Neil E Kay, et al.
British Journal of Haematology
|
April 8, 2017
CD49d associates with nodal presentation and subsequent development of lymphadenopathy in patients with chronic lymphocytic leukaemia
Paolo Strati, Sameer A Parikh, Kari G Chaffee, et al.
British Journal of Haematology
|
November 10, 2009
A comprehensive evaluation of the prognostic significance of 13q deletions in patients with B-chronic lymphocytic leukaemia
Daniel L Van Dyke, Tait D Shanafelt, Timothy G Call, et al.
Blood
|
October 12, 2023
Ibrutinib-based therapy reinvigorates CD8+ T cells compared to chemoimmunotherapy: immune monitoring from the E1912 trial
Despoina Papazoglou, Xin Victoria Wang, Tait D Shanafelt, et al.
British Journal of Haematology
|
October 12, 2013
Akt inhibitor MK2206 selectively targets CLL B-cell receptor induced cytokines, mobilizes lymphocytes and synergizes with bendamustine to induce CLL apoptosis
Wei Ding, Tait D Shanafelt, Connie E Lesnick, et al.
Molecular Cancer Therapeutics
|
August 13, 2015
Sphingosine Kinase-1 Protects Multiple Myeloma from Apoptosis Driven by Cancer-Specific Inhibition of RTKs
Shuntaro Tsukamoto, Yuhui Huang, Motofumi Kumazoe, et al.
Page
of 33
Search research articles
Search
Showing results (131-140 of 325) with videos related to
Sort By:
Page
of 33
Leukemia & Lymphoma
|
February 9, 2018
Reasons for initiation of treatment and predictors of response for patients with Rai stage 0/1 chronic lymphocytic leukemia (CLL) receiving first-line therapy: an analysis of the Connect<sup>®</sup> CLL cohort study
Christopher R Flowers, Chadi Nabhan, Neil E Kay, et al.
Cancer Genetics and Cytogenetics
|
December 16, 2010
Progressive but previously untreated CLL patients with greater array CGH complexity exhibit a less durable response to chemoimmunotherapy
Neil E Kay, Jeanette E Eckel-Passow, Esteban Braggio, et al.
Cancer Genetics and Cytogenetics
|
April 25, 2006
Metaphase cells with normal G-bands have cryptic interstitial deletions in 13q14 detectable by fluorescence in situ hybridization in B-cell chronic lymphocytic leukemia
Kimberly J Stockero, Stephanie R Fink, Stephanie A Smoley, et al.
Blood
|
May 6, 2009
De novo deletion 17p13.1 chronic lymphocytic leukemia shows significant clinical heterogeneity: the M. D. Anderson and Mayo Clinic experience
Constantine S Tam, Tait D Shanafelt, William G Wierda, et al.
Haematologica
|
August 6, 2013
Chronic lymphocytic leukemia in young (≤ 55 years) patients: a comprehensive analysis of prognostic factors and outcomes
Sameer A Parikh, Kari G Rabe, Neil E Kay, et al.
British Journal of Haematology
|
April 8, 2017
CD49d associates with nodal presentation and subsequent development of lymphadenopathy in patients with chronic lymphocytic leukaemia
Paolo Strati, Sameer A Parikh, Kari G Chaffee, et al.
British Journal of Haematology
|
November 10, 2009
A comprehensive evaluation of the prognostic significance of 13q deletions in patients with B-chronic lymphocytic leukaemia
Daniel L Van Dyke, Tait D Shanafelt, Timothy G Call, et al.
Blood
|
October 12, 2023
Ibrutinib-based therapy reinvigorates CD8+ T cells compared to chemoimmunotherapy: immune monitoring from the E1912 trial
Despoina Papazoglou, Xin Victoria Wang, Tait D Shanafelt, et al.
British Journal of Haematology
|
October 12, 2013
Akt inhibitor MK2206 selectively targets CLL B-cell receptor induced cytokines, mobilizes lymphocytes and synergizes with bendamustine to induce CLL apoptosis
Wei Ding, Tait D Shanafelt, Connie E Lesnick, et al.
Molecular Cancer Therapeutics
|
August 13, 2015
Sphingosine Kinase-1 Protects Multiple Myeloma from Apoptosis Driven by Cancer-Specific Inhibition of RTKs
Shuntaro Tsukamoto, Yuhui Huang, Motofumi Kumazoe, et al.
Page
of 33